Opioid Use Disorder: Endpoints for Demonstrating Effectiveness of Drugs for Treatment Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 1, 2020
October 5, 2020
88ee7ab4-2004-41c5-9b57-36cc6087d892
Related Documents
Acne Vulgaris: Establishing Effectiveness of Drugs Intended for Treatment
Guidance DocumentMay 22, 2018Center for Drug Evaluation and Research
Eosinophilic Esophagitis: Developing Drugs for Treatment Guidance for Industry
Guidance DocumentSeptember 15, 2020Center for Drug Evaluation and Research
Opioid Use Disorder: Developing Depot Buprenorphine Products for Treatment
Guidance DocumentFebruary 7, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox